Monitoring Agency Report

Date: November 02, 2026 To, To, The Manager The Manager Listing Department Listing Department Bombay Stock Exchange (BSE) National Stock Exchange (NSE) Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor Dalal Street Plot No. C/1, G-Block Mumbai - 400 001 Bandra-Kurla Complex Scrip Code: 544235 Bandra (E), Mumbai - 400 051 Symbol: ORIENTTECH Subject: MONITORING AGENCY REPORT FOR THE QUARTER ENDED ON SEPTEMBER 30, 2026. Dear Sir/Ma’am, Pursuant to Regulation 32(6) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 read with regulation 41(2) of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, please find enclosed Monitoring Agency report for the quarter ended on September 30, 2026. Kindly take the same on record. For ORIENT TECHNOLOGIES LIMITED Sayli Munj Company Secretary and Compliance Officer ACS-44432 Monitoring Agency Report No. CARE/HO/GEN/2026-27/1202 The Board of Directors Orient Technologies Limited 502, Akruti Star, Central Road, MIDC, Opposite Akruti Point Central, Andheri East, Mumbai – 400 093. November 02, 2026 Dear Sir/Ma’am, Monitoring Agency Report for the quarter ended September 30, 2026 - in relation to the Initial Public Offer (IPO) of Orient Technologies Limited (“the Company”) We write in our capacity of Monitoring Agency for the IPO for the amount aggregating to Rs. 120 crore of the Company and refer to our duties cast under Regulation 41 of the Securities & Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations. In this connection, we are enclosing the Monitoring Agency Report for the quarter ended September 30, 2026, as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated August 09, 2024. Request you to kindly take the same on records. Thanking you, Yours faithfully, Darshan Shah Associate Director Darshan.shah@careedge.in Monitoring Agency Report Report of the Monitoring Agency Name of the issuer: Orient Technologies Limited For quarter ended: September 30, 2026 Name of the Monitoring Agency: CARE Ratings Limited (a) Deviation from the objects: Yes, for issue expenses, the company has made payments to certain vendors including Goods and Services Tax (GST). However, as per the prospectus, the issue expenses are required to be paid excluding GST. (b) Range of Deviation: Up to 10% Declaration: We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit related analyses. We confirm that there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity. We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board. Signature: Name of the Authorized Signatory: Darshan Shah Designation of Authorized person/Signing Authority: Associate Director Monitoring Agency Report 1) Issuer Details: Name of the issuer : Orient Technologies Limited Name of the promoter : Ajay Sawant, Umesh Shah, Ujwal Mhatre, Jayesh Shah. Industry/sector to which it belongs : IT Services - IT Enabled Services 2) Issue Details Issue Period : August 21, 2024, to August 23, 2024 Type of issue (public/rights) : Initial Public Offer (IPO) Type of specified securities : Equity Shares IPO Grading, if any : Not applicable Issue size (in crore) : Rs. 120.00 crore 3) Details of the arrangement made to ensure the monitoring of issue proceeds: Source of information / certifications Comments of the Particulars Reply considered by Monitoring Agency for Comments of the Monitoring Agency Board of preparation of report Directors During this quarter, the company has utilized proceeds towards ‘Funding of capital expenditure requirements’ and ‘issue expenses’. The utilization of proceeds towards ‘Funding of capital expenditure requirements’ is as per the Prospectus. For issue expenses, the company has made payments to certain vendors including Goods and Services Tax (GST). Prospectus, Bank Statement, Invoices, However, as per the prospectus, the issue expenses are Whether all utilization is as per the disclosures in the Offer Special Resolution by Shareholders No comment No required to be paid excluding GST. Document? dated March 30, 2025, and March 26, received 2026 There was delay in utilization of proceeds towards ‘Funding of capital expenditure requirements’ and ‘General corporate purposes’ as compared to the Prospectus wherein the Company was required to utilize funds by the end of FY25. However, there was delay in the utilization and company, via Special Resolution dated March 30, 2025, obtained approval for deployment of unutilized proceeds by the end of FY26. Further, during Q4FY26, the Company passed another Monitoring Agency Report Source of information / certifications Comments of the Particulars Reply considered by Monitoring Agency for Comments of the Monitoring Agency Board of preparation of report Directors Special Resolution dated March 26, 2026, extending the timeline for deployment of unutilized proceeds by the end of FY27. As per the prospectus, the Company was required to utilize funds towards ‘Funding of capital expenditure requirements’ and ‘General corporate purposes’ by the end of FY25. The company, vide a Special Resolution dated March 30, 2025, obtained approval for deployment of unutilized proceeds by the end of FY26. Also, for the capital expenditure object, it Whether shareholder approval has been obtained in case Special Resolution by Shareholders has obtained approval for changes in vendor, specifications, No comment of material deviations# from expenditures disclosed in the Yes dated March 30, 2025, and March 26, and quantity. Payment is made to vendors mentioned in the received Offer Document? 2026 Prospectus as well as other vendors, which were not mentioned in the Prospectus however allowed by effect of the Special Resolution which allows to include adequate flexibility and selecting vendors. During Q4FY26, the Company passed another Special Resolution dated March 26, 2026, extending the timeline for deployment of unutilized proceeds by the end of FY27. Whether the means of finance for the disclosed objects of Prospectus and Management No comment No Not applicable the issue have changed? Certificate received Is t [Showing first 8,000 characters — download PDF for full document]